Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001780552 | SCV002232588 | pathogenic | not provided | 2021-06-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln511*) in the COL4A4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COL4A4 are known to be pathogenic (PMID: 21196518, 24854265, 25307543). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with COL4A4-related conditions. This variant is not present in population databases (ExAC no frequency). |
Fulgent Genetics, |
RCV002489829 | SCV002802935 | likely pathogenic | Autosomal recessive Alport syndrome; Benign familial hematuria | 2021-08-22 | criteria provided, single submitter | clinical testing |